However, if sick ribavirin injected, which were controlled breathing, the technical difficulties can cause unwanted effects in the non-compliance with the relevant precautions. The spread of drugs in the system depends on temperature, humidity and electrostatic forces. Deposition of the drug in the respiratory tubes and valves around the exit apparatus in the absence of correction could lead to a breach of function or blockage valve and completed undesirable high levels of positive end-expiratory pressure. To prevent these complications apply odnoklapannaya system on the line of breath and breathing filters on the line vydoha while carefully monitoring the condition of the patient.
There are currently studied distant effect ribavirin on lung function and aggravate respiratory syncytial virus. Pulmonary function of a small number of infants, made in the control group was investigated after a 2-4 year and has been in children who received ribavirin, not worse, than among children receiving a placebo.
Experience with other antiviral agents raises the issue of sustainability of respiratory syncytial virus to ribavirin. Change the sensitivity of any viral isolates to ribavirin lacking, even with prolonged use. But that experience observing very limited.
An analysis of the cost. It was unclear whether reduce the use of these expensive drugs cost of hospitalization of children with respiratory syncytial virus, as well as the cost of only one drug for 3 days the introduction of nearly 700 dollars.